These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 32816302)

  • 21. Health status of ayahuasca users.
    Barbosa PC; Mizumoto S; Bogenschutz MP; Strassman RJ
    Drug Test Anal; 2012; 4(7-8):601-9. PubMed ID: 22761152
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Behavioural and neurotoxic effects of ayahuasca infusion (Banisteriopsis caapi and Psychotria viridis) in female Wistar rat.
    Pic-Taylor A; da Motta LG; de Morais JA; Junior WM; Santos Ade F; Campos LA; Mortari MR; von Zuben MV; Caldas ED
    Behav Processes; 2015 Sep; 118():102-10. PubMed ID: 26049017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Shared functional connectome fingerprints following ritualistic ayahuasca intake.
    Mallaroni P; Mason NL; Kloft L; Reckweg JT; van Oorsouw K; Toennes SW; Tolle HM; Amico E; Ramaekers JG
    Neuroimage; 2024 Jan; 285():120480. PubMed ID: 38061689
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigation of Ayahuasca β-Carboline Alkaloids and Tryptamine in Sweat Samples from Religious Community Participants by GC-MS.
    Tavares L; Monedeiro F; Bordin DM; De Martinis BS
    J Anal Toxicol; 2020 Jul; 44(6):601-609. PubMed ID: 32103256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Ayahuasca in the Netherlands: what the doctor should know about its side effects].
    van den Berg A; van Eeghen EE; Kooter AJ; Tuinman TH; Tuinman PR
    Ned Tijdschr Geneeskd; 2020 Aug; 164():. PubMed ID: 32940978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical investigations of the therapeutic potential of ayahuasca: rationale and regulatory challenges.
    McKenna DJ
    Pharmacol Ther; 2004 May; 102(2):111-29. PubMed ID: 15163593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Associations between ayahuasca consumption in naturalistic settings and current alcohol and drug use: Results of a large international cross-sectional survey.
    Perkins D; Opaleye ES; Simonova H; Bouso JC; Tófoli LF; GalvÃo-Coelho NL; Schubert V; Sarris J
    Drug Alcohol Rev; 2022 Jan; 41(1):265-274. PubMed ID: 34308566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A rapid analytical strategy for the determination of ayahuasca alkaloids in non-ritualistic approaches by UHPLC-MS/MS.
    Eller S; Borges GR; Ossanes DS; Birk L; Scheid C; Yonamine M; Grossi P; Merib JO; Oliveira TF
    Forensic Sci Int; 2020 Jul; 312():110298. PubMed ID: 32387868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ritualistic Use of Ayahuasca versus Street Use of Similar Substances Seized by the Police: A Key Factor Involved in the Potential for Intoxications and Overdose?
    Lanaro R; Calemi DB; Togni LR; Costa JL; Yonamine M; Cazenave Sde O; Linardi A
    J Psychoactive Drugs; 2015; 47(2):132-9. PubMed ID: 25950593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autonomic, neuroendocrine, and immunological effects of ayahuasca: a comparative study with d-amphetamine.
    Dos Santos RG; Valle M; Bouso JC; Nomdedéu JF; Rodríguez-Espinosa J; McIlhenny EH; Barker SA; Barbanoj MJ; Riba J
    J Clin Psychopharmacol; 2011 Dec; 31(6):717-26. PubMed ID: 22005052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analytical techniques for the determination of tryptamines and β-carbolines in plant matrices and in psychoactive beverages consumed during religious ceremonies and neo-shamanic urban practices.
    Gaujac A; Navickiene S; Collins MI; Brandt SD; de Andrade JB
    Drug Test Anal; 2012; 4(7-8):636-48. PubMed ID: 22577086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ayahuasca in adolescence: Qaualitative results.
    de Rios MD; Grob CS; Lopez E; da Silviera DX; Alonso LK; Doering-Silveira E
    J Psychoactive Drugs; 2005 Jun; 37(2):135-9. PubMed ID: 16149325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is Ayahuasca an Option for the Treatment of Crack Cocaine Dependence?
    Cruz JI; Nappo SA
    J Psychoactive Drugs; 2018; 50(3):247-255. PubMed ID: 29608428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interview with Jeffrey Bronfman, representative mestre for the União do Vegetal Church in the United States. Interview by Marlene Dobkin de Rios and Charles S Grob.
    Bronfman J
    J Psychoactive Drugs; 2005 Jun; 37(2):189-91. PubMed ID: 16149332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determination of Tryptamines and β-Carbolines in Ayahuasca Beverage Consumed During Brazilian Religious Ceremonies.
    Santos MC; Navickiene S; Gaujac A
    J AOAC Int; 2017 May; 100(3):820-824. PubMed ID: 28105971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the Cytotoxicity of Ayahuasca Beverages.
    Simão AY; Gonçalves J; Gradillas A; García A; Restolho J; Fernández N; Rodilla JM; Barroso M; Duarte AP; Cristóvão AC; Gallardo E
    Molecules; 2020 Nov; 25(23):. PubMed ID: 33260723
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The potential use of ayahuasca in psychiatry].
    Frecska E; Bokor P; Andrassy G; Kovacs A
    Neuropsychopharmacol Hung; 2016 Jun; 18(2):79-86. PubMed ID: 27390204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Practices in search of legitimacy: the contemporary use of ayahuasca, between religious and therapeutic vindications].
    Dupuis D
    Salud Colect; 2018; 14(2):341-354. PubMed ID: 30281759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk assessment of ayahuasca use in a religious context: self-reported risk factors and adverse effects.
    Durante Í; Dos Santos RG; Bouso JC; Hallak JE
    Braz J Psychiatry; 2021; 43(4):362-369. PubMed ID: 33146343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of alpha oscillations through serotonin-2A receptor activation underlies the visual effects of ayahuasca in humans.
    Valle M; Maqueda AE; Rabella M; Rodríguez-Pujadas A; Antonijoan RM; Romero S; Alonso JF; Mañanas MÀ; Barker S; Friedlander P; Feilding A; Riba J
    Eur Neuropsychopharmacol; 2016 Jul; 26(7):1161-75. PubMed ID: 27039035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.